ICONLAB INC. v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

Case No. 8:16-cv-01321-JLS-KES.

ICONLAB INC., a California corporation, ICON LAB GmbH, a German corporation, REPER-NN, CO. LTD, a Russian corporation, Plaintiffs, v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC., a Delaware corporation; BAUSCH & LOMB INCORPORATED, a New York corporation; ANADOLU TIP TEKNOLOJILERI URETIM PAZARLAMA ITHALAT IHRACAT TICARET ve SANAYI ANONIM SIRKETI, a Turkish corporation, AND DOES 1-20, inclusive, Defendants.

United States District Court, C.D. California, Southern Division.

April 16, 2018.

Editors Note
Applicable Law: 28 U.S.C. § 1441
Cause: 28 U.S.C. § 1441 Notice of Removal
Nature of Suit: 190 Contract: Other
Source: PACER


Attorney(s) appearing for the Case

Iconlab Inc., a California Corporation, Iconlab GmbH, a German corporation & Reper NN, Co. Ltd., a Russian corporation, Plaintiffs, represented by David Young , David Young Law Offices.

Valeant Pharmaceuticals International, Inc., a Delaware Corporation, Valeant Holdings Ireland, an Irish corporation, Bausch and Lomb Incorporated, a New York corporation & Bausch and Lomb Saglik ve Optik Urunleri Tic A.S., a Turkish corporation, Defendants, represented by Moez M. Kaba , Hueston Hennigan LLP & Steven N. Feldman , Hueston Hennigan LLP.

Bausch and Lomb Incorporated, a New York corporation, Cross Claimant, represented by Douglas Wayne Robinson , Palmieri, Tyler, Wiener, Wilhelm & Waldron LLP, Gary M. Miller , Shook Hardy and Bacon LLP, Steven N. Feldman , Hueston Hennigan LLP & Tony M. Diab , Shook Hardy and Bacon LLP.

Valeant Pharmaceuticals International, Inc., a Delaware Corporation, Cross Claimant, represented by Douglas Wayne Robinson , Palmieri, Tyler, Wiener, Wilhelm & Waldron LLP, Gary M. Miller , Shook Hardy and Bacon LLP, Mayela Carmen Montenegro , Shook Hardy and Bacon LLP, Steven N. Feldman , Hueston Hennigan LLP & Tony M. Diab , Shook Hardy and Bacon LLP.


STIPULATED PROTECTIVE ORDER

1. PURPOSES, LIMITATIONS, AND GOOD CAUSE

A. Purposes and Limitations

Discovery in this action is likely to involve production of confidential, proprietary, competitively sensitive, or private information for which special...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases